Yancik R (2005) Population aging and cancer: a cross-national concern. Cancer J 11(6):437–441. https://doi.org/10.1097/00130404-200511000-00002
Lauko A, Rauf Y, Ahluwalia MS (2020) Medical management of brain metastases. Neurooncol Adv 2(1):vdaa015 Published 2020 Aug 9. https://doi.org/10.1093/noajnl/vdaa015
Article PubMed PubMed Central Google Scholar
Arvold ND, Lee EQ, Mehta MP et al (2016) Updates in the management of brain metastases. Neuro Oncol 18(8):1043–1065. https://doi.org/10.1093/neuonc/now127
Article PubMed PubMed Central Google Scholar
Soliman H, Das S, Larson DA, Sahgal A (2016) Stereotactic radiosurgery (SRS) in the modern management of patients with brain metastases. Oncotarget 7(11):12318–12330. https://doi.org/10.18632/oncotarget.7131
Article PubMed PubMed Central Google Scholar
Brown P, Asher A, Ballman K et al (2015) BMET-05: NCCTG N0574 (ALLIANCE): A PHASE III RANDOMIZED TRIAL OF WHOLE BRAIN RADIATION THERAPY (WBRT) IN ADDITION TO RADIOSURGERY (SRS) IN PATIENTS WITH 1 TO 3 BRAIN METASTASES. Neuro Oncol 17(Suppl 5):v45–v46. https://doi.org/10.1093/neuonc/nov208.05
Article PubMed Central Google Scholar
Aoyama H, Tago M, Kato N et al (2007) Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys 68(5):1388–1395. https://doi.org/10.1016/j.ijrobp.2007.03.048
Mahajan A, Ahmed S, McAleer MF et al (2017) Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial [published correction appears in Lancet Oncol.;18(8):e433] [published correction appears in Lancet Oncol. 2017;18(9):e510]. Lancet Oncol. 2017;18(8):1040–1048. https://doi.org/10.1016/S1470-2045(17)30414-X
Chang EL, Wefel JS, Hess KR et al (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10(11):1037–1044. https://doi.org/10.1016/S1470-2045(09)70263-3
Andrews DW, Scott CB, Sperduto PW et al (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363(9422):1665–1672. https://doi.org/10.1016/S0140-6736(04)16250-8
Palmer JD, Klamer BG, Ballman KV et al (2022) Association of Long-term outcomes with stereotactic radiosurgery vs whole-brain radiotherapy for resected brain metastasis: a secondary analysis of the N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) Randomized Clinical Trial. JAMA Oncol 8(12):1809–1815. https://doi.org/10.1001/jamaoncol.2022.5049
Article PubMed PubMed Central Google Scholar
Minniti G, Niyazi M, Andratschke N et al (2021) Current status and recent advances in resection cavity irradiation of brain metastases. Radiat Oncol 16:73. https://doi.org/10.1186/s13014-021-01802-9
Article PubMed PubMed Central Google Scholar
Abel RJ, Ji L, Yu C et al (2015) Stereotactic radiosurgery to the resection cavity for brain metastases: prognostic factors and outcomes. J Radiosurg SBRT 3(3):179–186
PubMed PubMed Central Google Scholar
Franzini A, Moosa S, Servello D et al (2019) Ablative brain surgery: an overview. Int J Hyperth 36(2):64–80. https://doi.org/10.1080/02656736.2019.1616833
Rennert RC, Carroll KT, Ali MA et al (2016) Safety of stereotactic laser ablations performed as treatment for glioblastomas in a conventional magnetic resonance imaging suite. Neurosurg Focus 41(4):E7. https://doi.org/10.3171/2016.8.FOCUS16217
Rennert RC, Khan U, Tatter SB et al (2018) Patterns of clinical use of stereotactic laser ablation: analysis of a multicenter prospective Registry. World Neurosurg 116:e566–e570. https://doi.org/10.1016/j.wneu.2018.05.039
Rennert RC, Khan U, Bartek J et al (2020) Laser ablation of abnormal neurological tissue using robotic Neuroblate System (LAANTERN): Procedural Safety and Hospitalization. Neurosurgery 86(4):538–547. https://doi.org/10.1093/neuros/nyz141
Johnson RA, Do TH, Palzer EF et al (2021) Pattern of technology diffusion in the adoption of stereotactic laser interstitial thermal therapy (LITT) in neuro-oncology. J Neurooncol 153(3):417–424. https://doi.org/10.1007/s11060-021-03760-4
Alattar AA, Bartek J Jr, Chiang VL et al (2019) Stereotactic laser ablation as treatment of Brain metastases recurring after stereotactic radiosurgery: a systematic literature review. World Neurosurg 128:134–142. https://doi.org/10.1016/j.wneu.2019.04.200
Peña Pino I, Ma J, Hori YS et al (2022) Stereotactic laser ablation (SLA) followed by consolidation stereotactic radiosurgery (cSRS) as treatment for brain metastasis that recurred locally after initial radiosurgery (BMRS): a multi-institutional experience. J Neurooncol 156(2):295–306. https://doi.org/10.1007/s11060-021-03893-6
Article CAS PubMed Google Scholar
Grabowski MM, Srinivasan ES, Vaios EJ et al (2022) Combination laser interstitial thermal therapy plus stereotactic radiotherapy increases time to progression for biopsy-proven recurrent brain metastases. Neurooncol Adv 4(1):vdac086 Published 2022 Jun 2. https://doi.org/10.1093/noajnl/vdac086
Article PubMed PubMed Central Google Scholar
Ali MA, Carroll KT, Rennert RC et al (2016) Stereotactic laser ablation as treatment for brain metastases that recur after stereotactic radiosurgery: a multiinstitutional experience. Neurosurg Focus 41(4):E11. https://doi.org/10.3171/2016.7.FOCUS16227
Rezaie P, Khoei S, Khoee S, Shirvalilou S, Mahdavi SR (2018) Evaluation of combined effect of hyperthermia and ionizing radiation on cytotoxic damages induced by IUdR-loaded PCL-PEG-coated magnetic nanoparticles in spheroid culture of U87MG glioblastoma cell line. Int J Radiat Biol 94(11):1027–1037 Epub 2018 Aug 21. PMID: 29985733
Article CAS PubMed Google Scholar
Overgaard J (1989) The current and potential role of hyperthermia in radiotherapy. Int J Radiat Oncol Biol Phys 16(3):535–549. https://doi.org/10.1016/0360-3016(89)90470-7
Article CAS PubMed Google Scholar
Dewey WC (2009) Arrhenius relationships from the molecule and cell to the clinic. Int J Hyperth 25(1):3–20. https://doi.org/10.1080/02656730902747919
Datta NR, Ordóñez SG, Gaipl US et al (2015) Local hyperthermia combined with radiotherapy and-/or chemotherapy: recent advances and promises for the future. Cancer Treat Rev 41(9):742–753. https://doi.org/10.1016/j.ctrv.2015.05.009
Article CAS PubMed Google Scholar
Grauer O, Jaber M, Hess K et al (2019) Combined intracavitary thermotherapy with iron oxide nanoparticles and radiotherapy as local treatment modality in recurrent glioblastoma patients. J Neurooncol 141(1):83–94. https://doi.org/10.1007/s11060-018-03005-x
Article CAS PubMed Google Scholar
Sharma M, Do TH, Palzer EF, Huling JD, Chen CC (2023) Comparable safety profile between neuro-oncology procedures involving stereotactic needle biopsy (SNB) followed by laser interstitial thermal therapy (LITT) and LITT alone procedures. J Neurooncol 162(1):147–156. https://doi.org/10.1007/s11060-023-04275-w
Do TH, Howard MA, Palzer EF et al (2022) Readmission risk of malignant brain tumor patients undergoing laser interstitial thermal therapy (LITT) and stereotactic needle biopsy (SNB): a covariate balancing weights analysis of the National readmissions database (NRD). J Neurooncol 159(3):553–561. https://doi.org/10.1007/s11060-022-04093-6
Vogt A, Schmid S, Heinimann K et al (2017) Multiple primary tumours: challenges and approaches, a review. ESMO Open 2(2):e000172 Published 2017 May 2. https://doi.org/10.1136/esmoopen-2017-000172
Article PubMed PubMed Central Google Scholar
Loi M, Caini S, Scoccianti S et al (2020) Stereotactic reirradiation for local failure of brain metastases following previous radiosurgery: systematic review and meta-analysis. Crit Rev Oncol Hematol 153:103043. https://doi.org/10.1016/j.critrevonc.2020.103043
留言 (0)